Home › Funds › Smith Salley Wealth Management › ELV

Smith Salley Wealth Management position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Smith Salley Wealth Management reported holding 40,819 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$15.9M, representing 0.66% of its reported portfolio and ranking #41 among its reported holdings. Smith Salley Wealth Management has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)40.82K sh
Reported value held$15.87M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Smith Salley Wealth Management's ELV position evolved

Smith Salley Wealth Management first disclosed a stake in ELV in Q3 2023 at 30,431 shares (US$13.2M). The position peaked in Q2 2024 at 30,270 shares, worth US$16.4M. Across 13 filings, Smith Salley Wealth Management increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 40,819 shares valued at US$15.9M — an increase of 1,112 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 30.43K $13.25M New
Q4 2023 31.99K $15.08M Add
Q1 2024 28.51K $14.78M Reduce
Q2 2024 30.27K $16.40M Add
Q3 2024 31.09K $16.16M Add
Q4 2024 29.70K $10.96M Reduce
Q1 2025 30.65K $13.33M Add
Q2 2025 31.63K $12.30M Add
Q3 2025 39.85K $12.88M Add
Q4 2025 38.09K $13.35M Reduce
Q1 2026 39.51K $11.57M Add
Q2 2026 39.71K $15.36M Hold
Q3 2026 40.82K $15.87M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Smith Salley Wealth Management held ELV?

Smith Salley Wealth Management has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Smith Salley Wealth Management's current position in ELV?

As of Q3 2026, Smith Salley Wealth Management holds 40.82K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $15.87M, representing 0.66% of its reported portfolio and ranking #41.

Has Smith Salley Wealth Management been buying or selling ELV?

In the latest 13F filing (Q3 2026), Smith Salley Wealth Management increased its position in ELV. The position peaked in Q2 2024 at 30.27K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.